Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Hepatic response in AL amyloidosis (Alk phos >50% reduction/normalization) associated with improved survival independent of other factors; predictors = high baseline Alk phos, lower t-bili, heme ≥VGPR, cardiac and renal response.”
Title: Hepatic response criteria in light chain amyloidosis: a multicenter validation study
Authors: Eli Muchtar, Giovanni Palladini, Stefan Schonland, Susan Geyer, Katharine E. Dooley, Angela Dispenzieri, Brendan Wisniowski, Giampaolo Merlini, Paolo Milani, Ute Hegenbart, Tobias Dittrich, Efstathios Kastritis, Meletios A. Dimopoulos, Vaishali Sanchorawala, Raphael Szalat, Michaela Liedtke, Mani Gupta, Heather Landau, Suzanne Lentzsch, Michael S. Hughes, Maria Teresa Cibeira, Joan Blade, Shaji K. Kumar, Ashutosh Wechalekar, and Morie A. Gertz
You can read the Full Article in Haematologica.
You can find more posts featuring Robert Orlowski on OncoDaily.
